Related references
Note: Only part of the references are listed.Immune targets and neoantigens for cancer immunotherapy and precision medicine
Rong-Fu Wang et al.
CELL RESEARCH (2017)
Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression
Maria Parkhurst et al.
CLINICAL CANCER RESEARCH (2017)
Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer
Valsamo Anagnostou et al.
CANCER DISCOVERY (2017)
The movers and shapers in immune privilege of the CNS
Britta Engelhardt et al.
NATURE IMMUNOLOGY (2017)
Personalized cancer immunotherapy using Systems Medicine approaches
Shailendra K. Gupta et al.
BRIEFINGS IN BIOINFORMATICS (2016)
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
Eric Bouffet et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
Jonathan E. Rosenberg et al.
LANCET (2016)
Neoantigen landscape dynamics during human melanoma-T cell interactions
Els M. E. Verdegaal et al.
NATURE (2016)
Clonal evolution of glioblastoma under therapy
Jiguang Wang et al.
NATURE GENETICS (2016)
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients
Alena Gros et al.
NATURE MEDICINE (2016)
Computational genomics tools for dissecting tumour-immune cell interactions
Hubert Hackl et al.
NATURE REVIEWS GENETICS (2016)
T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer
Eric Tran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
Nicholas McGranahan et al.
SCIENCE (2016)
Targeting of cancer neoantigens with donor-derived T cell receptor repertoires
Erlend Stronen et al.
SCIENCE (2016)
Cancer immunotherapy targeting neoantigens
Yong-Chen Lu et al.
SEMINARS IN IMMUNOLOGY (2016)
Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry
Michal Bassani-Sternberg et al.
NATURE COMMUNICATIONS (2016)
Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy
Tanner M. Johanns et al.
CANCER DISCOVERY (2016)
pVAC-Seq: A genome-guided in silico approach to identifying tumor neoantigens
Jasreet Hundal et al.
GENOME MEDICINE (2016)
Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade
Douglas B. Johnson et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor Antigens
Todd D. Prickett et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Endogenous Neoantigen-Specific CD8 T Cells Identified in Two Glioblastoma Models Using a Cancer Immunogenomics Approach
Tanner M. Johanns et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Low Mutation Burden in Ovarian Cancer May Limit the Utility of Neoantigen-Targeted Vaccines
Spencer D. Martin et al.
PLOS ONE (2016)
Spatiotemporal Evolution of the Primary Glioblastoma Genome
Jinkuk Kim et al.
CANCER CELL (2015)
Increased proportion of FoxP3+regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma
Elias J. Sayour et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
Michael S. Rooney et al.
CELL (2015)
Proteogenomics meets cancer immunology: mass spectrometric discovery and analysis of neoantigens
Anna Polyakova et al.
EXPERT REVIEW OF PROTEOMICS (2015)
Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes
Cyrille J. Cohen et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Tumor neoantigens: building a framework for personalized cancer immunotherapy
Matthew M. Gubin et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules
Aleksanteri Aspelund et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Viral Infection of Tumors Overcomes Resistance to PD-1-immunotherapy by Broadening Neoantigenome-directed T-cell Responses
Norman Woller et al.
MOLECULAR THERAPY (2015)
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
Sebastian Kreiter et al.
NATURE (2015)
Structural and functional features of central nervous system lymphatic vessels
Antoine Louveau et al.
NATURE (2015)
Clearance systems in the brain-implications for Alzheimer disease
Jenna M. Tarasoff-Conway et al.
NATURE REVIEWS NEUROLOGY (2015)
Somatic POLE mutations cause an ultramutated giant cell high-grade glioma subtype with better prognosis
E. Zeynep Erson-Omay et al.
NEURO-ONCOLOGY (2015)
A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study
James Schuster et al.
NEURO-ONCOLOGY (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
Jeanette E. Eckel-Passow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
Daniel J. Brat et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
Eliezer M. Van Allen et al.
SCIENCE (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
Immunogenicity of somatic mutations in human gastrointestinal cancers
Eric Tran et al.
SCIENCE (2015)
A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
Beatriz M. Carreno et al.
SCIENCE (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
Exome Sequencing to Predict Neoantigens in Melanoma
Antonia L. Pritchard et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Strong spontaneous tumor neoantigen responses induced by a natural human carcinogen
Jenette Creaney et al.
ONCOIMMUNOLOGY (2015)
Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma
Anna Sophie Berghoff et al.
NEURO-ONCOLOGY (2015)
Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia
Mohini Rajasagi et al.
BLOOD (2014)
A survey of tools for variant analysis of next-generation genome sequencing data
Stephan Pabinger et al.
BRIEFINGS IN BIOINFORMATICS (2014)
Tumour-infiltrating CD4+ and CD8+ lymphocytes as predictors of clinical outcome in glioma
S. Han et al.
BRITISH JOURNAL OF CANCER (2014)
Surveillance of the Tumor Mutanome by T Cells during Progression from Primary to Recurrent Ovarian Cancer
Darin A. Wick et al.
CLINICAL CANCER RESEARCH (2014)
Efficient Identification of Mutated Cancer Antigens Recognized by T Cells Associated with Durable Tumor Regressions
Yong-Chen Lu et al.
CLINICAL CANCER RESEARCH (2014)
Rindopepimut: a promising immunotherapeutic for the treatment of glioblastoma multiforme
Adam M. Swartz et al.
IMMUNOTHERAPY (2014)
Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity
Fei Duan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
The prognostic value of Foxp3+tumor-infiltrating lymphocytes in patients with glioblastoma
Qi Yue et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Matthew M. Gubin et al.
NATURE (2014)
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
Mahesh Yadav et al.
NATURE (2014)
A vaccine targeting mutant IDH1 induces antitumour immunity
Theresa Schumacher et al.
NATURE (2014)
Molecular and cellular heterogeneity: the hallmark of glioblastoma
Diane J. Aum et al.
NEUROSURGICAL FOCUS (2014)
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Alexandra Snyder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma
Brett E. Johnson et al.
SCIENCE (2014)
Cancer Immunotherapy Based on Mutation-Specific CD4+T Cells in a Patient with Epithelial Cancer
Eric Tran et al.
SCIENCE (2014)
Choice of transcripts and software has a large effect on variant annotation
Davis J. McCarthy et al.
GENOME MEDICINE (2014)
HLA-Binding Properties of Tumor Neoepitopes in Humans
Edward F. Fritsch et al.
CANCER IMMUNOLOGY RESEARCH (2014)
High sensitivity of cancer exome-based CD8 T cell neo-antigen identification
Marit M. van Buuren et al.
ONCOIMMUNOLOGY (2014)
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
Pierre G. Coulie et al.
NATURE REVIEWS CANCER (2014)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
HLA ligandome tumor antigen discovery for personalized vaccine approach
Hans-Georg Rammensee et al.
EXPERT REVIEW OF VACCINES (2013)
Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive Melanoma
Nienke van Rooij et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Characterization of the blood-brain barrier of metastatic and primary malignant neoplasms Laboratory investigation
Edjah K. Nduom et al.
JOURNAL OF NEUROSURGERY (2013)
Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells
Paul F. Robbins et al.
NATURE MEDICINE (2013)
Exploiting the Mutanome for Tumor Vaccination
John C. Castle et al.
CANCER RESEARCH (2012)
Emerging insights into the molecular and cellular basis of glioblastoma
Gavin P. Dunn et al.
GENES & DEVELOPMENT (2012)
The disturbed blood-brain barrier in human glioblastoma
Hartwig Wolburg et al.
MOLECULAR ASPECTS OF MEDICINE (2012)
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
Hirokazu Matsushita et al.
NATURE (2012)
Expression of tumour-specific antigens underlies cancer immunoediting
Michel DuPage et al.
NATURE (2012)
The anatomical and cellular basis of immune surveillance in the central nervous system
Richard M. Ransohoff et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Effector T-Cell Infiltration Positively Impacts Survival of Glioblastoma Patients and Is Impaired by Tumor-Derived TGF-β
Jennifer Lohr et al.
CLINICAL CANCER RESEARCH (2011)
CD8+T-cell infiltrate in newly diagnosed glioblastoma is associated with long-term survival
Isaac Yang et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2010)
Vaccine provides new hope for patients with deadly brain cancer
[Anonymous]
FUTURE NEUROLOGY (2010)
Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma
John H. Sampson et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Infiltrating CTLs in Human Glioblastoma Establish Immunological Synapses with Tumorigenic Cells
Carlos Barcia et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
NetMHCpan, a method for MHC class I binding prediction beyond humans
Ilka Hoof et al.
IMMUNOGENETICS (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
An introduction to epitope prediction methods and software
Xingdong Yang et al.
REVIEWS IN MEDICAL VIROLOGY (2009)
Evaluation of MHC class I peptide binding prediction servers: Applications for vaccine research
Hong Huang Lin et al.
BMC IMMUNOLOGY (2008)
Epitope landscape in breast and colorectal cancer
Neil H. Segal et al.
CANCER RESEARCH (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology
R. O. Carare et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2008)
Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment
Daniel P. Cahill et al.
CLINICAL CANCER RESEARCH (2007)
A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy
C Hunter et al.
CANCER RESEARCH (2006)
Autoantibodies against GLEA2 and PHF3 in glioblastoma:: Tumor-associated autoantibodies correlated with prolonged survival
CP Pallasch et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Differential induction of interleukin-1β and tumour necrosis factor-α may account for specific patterns of leukocyte recruitment in the brain
D Blond et al.
BRAIN RESEARCH (2002)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
Site-specific immune response to implanted gliomas
MA Proescholdt et al.
JOURNAL OF NEUROSURGERY (2001)
Share Paper
